Connolly C C, Adkins-Marshall B A, Neal D W, Pugh W, Jaspan J B, Cherrington A D
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Diabetes. 1992 Oct;41(10):1308-19. doi: 10.2337/diab.41.10.1308.
To determine the relationship between decreases in glucose and metabolic regulation in the absence of counterregulatory hormones, we infused overnight-fasted, conscious, adrenalectomized dogs (lacking cortisol and EPI) with somatostatin (to eliminate glucagon and growth hormone) and intraportal insulin (30 pmol.kg-1.min-1), creating arterial insulin levels of approximately 2000 pM. Glucose was infused during one 120-min period, two 90-min periods, and one 45-min period to establish levels of 5.9 +/- 0.1, 3.4 +/- 0.1, 2.5 +/- 0.1, and 1.7 +/- 0.1 mM, respectively. NE levels were 1.24 +/- 0.23, 1.85 +/- 0.27, 2.04 +/- 0.26, and 2.50 +/- 0.20 nM, respectively. During the euglycemic control period, the liver took up glucose (7.5 +/- 1.9 mumol.kg-1.min-1), but hypoglycemia triggered successively greater rates of net hepatic glucose output (3.0 +/- 0.7, 4.6 +/- 0.9, and 6.9 +/- 1.4 mumol.kg-1.min-1). Total gluconeogenic precursor uptake by the liver increased with hypoglycemia. Intrahepatic gluconeogenic efficiency rose progressively (by 106 +/- 42, 199 +/- 56, and 268 +/- 55%). Both glycerol and NEFA levels rose, indicating lipolysis was enhanced. Net hepatic NEFA uptake and ketone production increased proportionally, but the ketone level rose only with severe hypoglycemia. In conclusion, despite marked hyperinsulinemia and the absence of glucagon, EPI, and cortisol, we observed that lipolysis and glucose and ketone production increase in response to decreases in glucose. This suggests that neural and/or autoregulatory mechanisms can play a role in combating hypoglycemia.
为了确定在缺乏对抗调节激素的情况下血糖降低与代谢调节之间的关系,我们对过夜禁食、清醒的肾上腺切除犬(缺乏皮质醇和肾上腺素)进行静脉输注生长抑素(以消除胰高血糖素和生长激素)和门静脉内胰岛素(30 pmol·kg⁻¹·min⁻¹),使动脉胰岛素水平达到约2000 pM。在一个120分钟时间段、两个90分钟时间段和一个45分钟时间段内输注葡萄糖,以使血糖水平分别达到5.9±0.1、3.4±0.1、2.5±0.1和1.7±0.1 mM。去甲肾上腺素水平分别为1.24±0.23、1.85±0.27、2.04±0.26和2.50±0.20 nM。在血糖正常的对照期,肝脏摄取葡萄糖(7.5±1.9 μmol·kg⁻¹·min⁻¹),但低血糖依次引发更高的肝脏净葡萄糖输出率(3.0±0.7、4.6±0.9和6.9±1.4 μmol·kg⁻¹·min⁻¹)。随着低血糖发生,肝脏总的糖异生前体摄取增加。肝内糖异生效率逐渐升高(分别升高106±42%、199±56%和268±55%)。甘油和非酯化脂肪酸水平均升高,表明脂肪分解增强。肝脏净非酯化脂肪酸摄取和酮体生成成比例增加,但仅在严重低血糖时酮体水平升高。总之,尽管存在明显的高胰岛素血症且缺乏胰高血糖素、肾上腺素和皮质醇,但我们观察到脂肪分解以及葡萄糖和酮体生成会随着血糖降低而增加。这表明神经和/或自身调节机制在对抗低血糖中可能发挥作用。